Eli Lilly – News Stories About Eli Lilly - Page 1

Look Out, Ozempic, Rival Weight-Loss Drug Is Near

New Drug Poised to Take
Weight-Loss Throne

Apr 9, 2023 2:25 PM CDT

New Drug Poised to Take Weight-Loss Throne

Eli Lilly's Mounjaro is outperforming Ozempic in clinical trials

(Newser) - Get ready to hear a lot about a weight-loss drug called Mounjaro . Eli Lilly & Co.'s anti-obesity drug has demonstrated significant weight-loss results in clinical trials, so much so that the Wall Street Journal refers to it as the "King Kong" of such drugs. US health regulators...

Eli Lilly Makes a 'Good Guy'
Move on Insulin Prices

Mar 1, 2023 8:06 AM CST

Eli Lilly Makes a 'Good Guy' Move on Insulin Prices

It's cutting list price for its most commonly prescribed insulin by 70%

(Newser) - Some relief, at long last, for diabetics, who can pay as much as $1,000 a month for the insulin they require: Eli Lilly on Wednesday announced that it will be slashing insulin prices, some immediately and some later this year.

Lilly will cut the list price for its most

...

Company Opposed to Abortion Law Was Slow to Say So

Eli Lilly Faces
Questions Over
Abortion Stance

Aug 10, 2022 7:35 PM CDT

Eli Lilly Faces Questions Over Abortion Stance

Company donated to Indiana legislators behind the restrictions

(Newser) - Eli Lilly's suggestion that it will reconsider adding employees in Indiana in light of its new, nearly total restrictions on abortions might have seemed like it would encourage opponents of the law—one of the state's largest employers exerting leverage on behalf of its position. But the response...

Another Company to Ask FDA
to Approve Alzheimer's Drug

Jun 24, 2021 7:10 PM CDT

Another Company to Ask FDA to Approve Alzheimer's Drug

Biogen just won approval for its treatment despite experts' dissent

(Newser) - Eli Lilly is nearly ready to take another shot at getting approval for a possible Alzheimer's drug. The drugmaker said Thursday that it plans to submit its potential treatment donanemab to the Food and Drug Administration later this year. The announcement comes a few weeks after the FDA approved...

Experimental
Treatment
Given to Trump
Wins Approval

Nov 22, 2020 7:44 AM CST

Experimental Treatment Given to Trump Wins Approval

FDA clears Regeneron for emergency use against COVID

(Newser) - Regeneron's experimental antibody treatment received emergency authorization on Saturday, clearing the way for patients to receive the same therapy given President Trump during his bout with COVID-19. The pharmaceutical company had told the Food and Drug Administration that trial data indicated that the treatment cut the number of medical...

More Good COVID News
From the Pharma Industry

Nov 10, 2020 3:40 AM CST

More Good COVID News From the Pharma Industry

Eli Lilly's antibody drug gets emergency use approval

(Newser) - On the same day Pfizer announced its big news on the coming coronavirus vaccine, more positive news from the pharmaceutical industry: Eli Lilly's experimental antibody drug has been given the green light by the FDA. Bamlanivimab, the first such drug to help the immune system fight COVID-19, is now...

Drugmaker Pauses Trial
of COVID Antibody Treatment

Oct 14, 2020 7:31 AM CDT

Drugmaker Pauses Trial of COVID Antibody Treatment

Eli Lilly says it's for safety reasons, without elaborating

(Newser) - Drugmaker Eli Lilly, working to come up with an antibody treatment for COVID-19, has paused its phase three clinical trials after an independent data safety monitoring board (DSMB) raised concerns. "Safety is of the utmost importance to Lilly," a company spokeswoman said in a statement Tuesday, reports CNBC...

Mar 4, 2019 4:31 PM CST

Popular Diabetes Drug Gets Half-Priced Alternative

Eli Lilly announces 'authorized generic' version of Humalog insulin

(Newser) - Drug-maker Eli Lilly is coming out with a half-priced version of its popular insulin Humalog. In fact, the drug called Insulin Lispro will be identical to Humalog except for its packaging and its price—it will cost $137.50 per vial, or 50% less than Humalog, reports the New York ...

Most-Hated
Firm in America
Has 'String of
PR Disasters'

Jan 11, 2019 12:55 PM CST

Most-Hated Firm in America Has 'String of PR Disasters'

Facebook really gets our goat, per 24/7 Wall St.

(Newser) - The opposite of love may be indifference, but hate is what Americans harbor for the companies that annoy, enrage, and frustrate them. And those firms fall in a variety of sectors, per 24/7 Wall St ., which ranked the most loathed companies in the country based on consumer surveys, data from...

2 Antidepressants Linked
to Birth Defects

STUDY SAYS

Jul 10, 2015 4:20 PM CDT

2 Antidepressants Linked to Birth Defects

Paxil and Prozac implicated; newer SSRIs like Zoloft, Celexa cleared

(Newser) - A CDC study of almost 28,000 women has shown links between use of the antidepressants Paxil and Prozac and birth defects, Reuters reports. The study, published in the British Medical Journal , sought to answer long-debated questions about the effect of taking selective serotonin reuptake inhibitors, or SSRIs, during pregnancy,...

Cialis Maker
Wants to Sell It
Over the
Counter

May 28, 2014 6:07 PM CDT

Cialis Maker Wants to Sell It Over the Counter

Eli Lilly seeks change for impotence drug

(Newser) - Cialis is already the world's best-selling impotence drug, and its makers hope to significantly ramp up sales by making it available over the counter, reports Reuters . Eli Lilly has struck a deal with French drug-maker Sanofi to sell a non-prescription version, assuming they first win the permission of health...

Disgraced Doctors
Land at Big Pharma

investigation

Oct 19, 2010 7:59 AM CDT

Disgraced Doctors Land at Big Pharma

Hundreds of pitchmen found to have blemished records

(Newser) - Pharmaceutical companies say they hire highly respected doctors as their white-coat sales force, peddling their drugs to other physicians. But a Pro Publica investigation has discovered that hundreds of these pitchmen have been accused of professional misconduct, been disciplined by state boards, or lacked credentials. Medical board records in the...

$75M in Prescription Drugs Snatched in Warehouse Heist

Mar 17, 2010 1:45 AM CDT

$75M in Prescription Drugs Snatched in Warehouse Heist

Antidepressants, anti-psychotics snatched in brazen operation

(Newser) - Thieves made off with an estimated $75 million in prescription drugs after a well-planned heist at Eli Lilly's Connecticut warehouse. The thieves cut a hole in the huge building's roof and lowered themselves down on ropes before loading multiple pallets of drugs onto at least one tractor-trailer truck, police tell...

Big Pharma Flouts Laws
on Off-Label Uses

Nov 9, 2009 8:19 AM CST

Big Pharma Flouts Laws on Off-Label Uses

Billions in fines don't stop illegal promotion

(Newser) - Back in 2004, a unit of drug giant Pfizer pleaded guilty to marketing a drug, Neurotonin, for unapproved uses, paid $430 million in fines, and promised to clean up its act—which it had no intention of doing. "At the very same time Pfizer was in our office negotiating...

Novartis Acquires Plavix Rival

Feb 12, 2009 8:22 AM CST

Novartis Acquires Plavix Rival

Novartis acquires worldwide rights from a San Francisco biopharmaceutical firm

(Newser) - Novartis AG will pay a San Francisco biopharmaceutical company $75 million—with the potential for an additional $500 million—for the worldwide rights to an experimental anticlotting drug the Swiss drug firm hopes will rival Plavix, reports the Wall Street Journal. Market leader Plavix rang up $8.22 billion in...

Eli Lilly to Pay $1.4B, Plead Guilty in Marketing Scheme

Jan 15, 2009 3:50 PM CST

Eli Lilly to Pay $1.4B, Plead Guilty in Marketing Scheme

Company promoted drug for unapproved uses

(Newser) - Eli Lilly will plead guilty to a federal misdemeanor and pay $1.42 billion to settle investigations into its marketing of an anti-schizophrenia drug, Reuters reports. The company promoted Zyprexa to the elderly as an anti-dementia pharmaceutical, though studies questioned its effectiveness in treating Alzheimer’s. “Eli Lilly had...

Stocks Skid on Jobs Numbers

MARKET Open

Dec 11, 2008 8:52 AM CST

Stocks Skid on Jobs Numbers

(Newser) - Stocks dipped at the open today, thanks to a sharp jump in jobless claims and more negative corporate news. The Dow fell 119 points, while the S&P and Nasdaq dropped 1.2% and 1.5% respectively, after the Labor Department announced that new unemployment claims hit a 26-year high...

Polly Want a Prozac?

Feb 26, 2008 9:33 AM CST

Polly Want a Prozac?

Parrots are the latest pets to see spike in depression

(Newser) - With more pet owners working long days and leaving their furry and feathered friends alone at home, cases of animal depression are on the rise, writes the Daily Telegraph. A TV vet says the trend is hitting parrots especially hard, causing the talkative birds to pull out their feathers or...

Antidepressants Mostly Useless, Study Finds

Feb 26, 2008 7:41 AM CST

Antidepressants Mostly Useless, Study Finds

Prozac and others make a difference only in most extreme cases

(Newser) - Big Pharma swallowed a bitter pill yesterday as Prozac and other antidepressants were found in a UK study to be largely ineffectual in all but the most extreme cases of depression. The meta-analysis of 47 clinical trials submitted to the FDA with licensing applications for six popular antidepressants concluded that...

Eli Lilly Could Pay $1B Settlement

Jan 30, 2008 5:40 PM CST

Eli Lilly Could Pay $1B Settlement

Fine for illegally promoting antipsychotic drug Zyprexa would be biggest ever

(Newser) - Drug-maker Eli Lilly could pay more than $1 billion to state and federal authorities to settle an investigation into how the company marketed an antipsychotic drug, the New York Times reports. In 2000-03, Lilly pushed doctors to prescribe Zyprexa as a treatment for age-related dementia—though the drug is approved...